HROW
Harrow, Inc.
NasdaqGMUSDEQUITY
DELAYED
Last price
40.95
▼ 1.11 (2.64%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
42.41
Prev close
42.06
Day high
42.70
Day low
40.81
Volume
391.92K
Market cap
—
P/E (TTM)
—
52W range
28.54 – 54.85
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+2.30%
+3.7%
1M
-2.22%
-6.0%
3M
+24.24%
+21.1%
6M
-21.25%
-32.3%
YTD
-16.43%
-28.7%
1Y
+7.11%
-12.9%
3Y
+140.88%
+66.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $272.30M | $199.61M | $130.19M | $88.59M | +36.4% |
| Operating revenue | $271.91M | $198.62M | $117.45M | $88.59M | +36.9% |
| Cost of revenue | $67.93M | $49.24M | $39.64M | $25.38M | +38.0% |
| Gross profit | $204.37M | $150.37M | $90.55M | $63.21M | +35.9% |
| Research & development | $20.94M | $12.23M | $6.65M | $3.05M | +71.2% |
| Selling, general & admin | $152.91M | $129.06M | $83.09M | $58.24M | +18.5% |
| Total operating expense | $173.85M | $141.29M | $89.74M | $61.29M | +23.0% |
| Operating income | $30.52M | $9.07M | $811.00K | $1.92M | +236.3% |
| Net interest income | -$24.18M | -$22.79M | -$21.32M | -$7.24M | -6.1% |
| Pre-tax income | -$1.37M | -$17.32M | -$23.71M | -$14.01M | +92.1% |
| Tax provision | $3.77M | $161.00K | $701.00K | $75.00K | +2,242.2% |
| Net income | -$5.14M | -$17.48M | -$24.41M | -$14.09M | +70.6% |
| Net income to common | -$5.14M | -$17.48M | -$24.41M | -$14.09M | +70.6% |
| Basic EPS | -0.14 | -0.49 | -0.75 | -0.51 | +71.4% |
| Diluted EPS | -0.14 | -0.49 | -0.75 | -0.51 | +71.4% |
| EBIT | $22.81M | $5.47M | -$2.39M | -$6.77M | +317.3% |
| EBITDA | $42.49M | $20.00M | $9.95M | -$3.10M | +112.4% |
| Basic shares | 36.71M | 35.65M | 32.62M | 27.62M | +3.0% |
| Diluted shares | 36.71M | 35.65M | 32.62M | 27.62M | +3.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $72.93M | $47.25M | $74.08M | $96.27M | +54.4% |
| Cash & short-term investments | $72.93M | $47.25M | $82.77M | $101.86M | +54.4% |
| Accounts receivable | $110.89M | $116.37M | $36.26M | $6.25M | -4.7% |
| Inventory | $13.52M | $10.70M | $10.87M | $6.54M | +26.4% |
| Total current assets | $211.75M | $189.65M | $139.48M | $118.26M | +11.7% |
| Property, plant & equipment | $11.04M | $12.29M | $10.31M | $11.00M | -10.1% |
| Goodwill & intangibles | $176.69M | $187.03M | $162.38M | $26.17M | -5.5% |
| Total assets | $399.48M | $388.97M | $312.16M | $157.38M | +2.7% |
| Total current liabilities | $96.30M | $91.34M | $49.34M | $18.63M | +5.4% |
| Long-term debt | $243.18M | $219.54M | $185.88M | $104.17M | +10.8% |
| Total debt | $251.98M | $228.83M | $193.22M | $112.23M | +10.1% |
| Total liabilities | $347.39M | $319.67M | $241.75M | $130.14M | +8.7% |
| Retained earnings | -$156.52M | -$151.38M | -$133.90M | -$109.49M | -3.4% |
| Shareholder equity | $52.45M | $69.65M | $70.77M | $27.59M | -24.7% |
| Working capital | $115.45M | $98.31M | $90.14M | $99.63M | +17.4% |
| Net tangible assets | -$124.24M | -$117.38M | -$91.61M | $1.43M | -5.8% |
| Shares issued | 37.23M | 35.62M | 35.17M | 29.90M | +4.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$5.14M | -$17.48M | -$24.41M | -$14.09M | — | +70.6% |
| Depreciation & amortisation | $19.68M | $14.54M | $12.34M | $3.67M | — | +35.4% |
| Stock-based compensation | $12.50M | $17.62M | $15.70M | $7.97M | — | -29.0% |
| Change in working capital | $185.00K | -$44.63M | -$7.13M | -$5.57M | — | +100.4% |
| Operating cash flow | $43.86M | -$22.20M | $3.84M | $1.71M | — | +297.6% |
| Capital expenditure | -$1.10M | -$38.67M | -$152.55M | -$7.77M | — | +97.2% |
| Investing cash flow | -$5.46M | -$33.16M | -$152.55M | -$1.74M | — | +83.5% |
| Share buybacks | — | — | — | $0 | -$11.00M | — |
| Dividends paid | — | — | — | $0 | -$127.00K | — |
| Financing cash flow | -$12.72M | $28.53M | $126.53M | $54.14M | — | -144.6% |
| Free cash flow | $42.76M | -$60.88M | -$148.71M | -$6.07M | — | +170.2% |
| End cash position | $72.93M | $47.25M | $74.08M | $96.27M | — | +54.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $44.20M | $89.09M | $71.64M | $63.74M | $47.83M | — | -50.4% |
| Operating revenue | $44.13M | $89.01M | $71.50M | $63.66M | $47.74M | — | -50.4% |
| Cost of revenue | $17.16M | $18.47M | $17.71M | $16.23M | $15.52M | — | -7.1% |
| Gross profit | $27.05M | $70.62M | $53.93M | $47.51M | $32.31M | — | -61.7% |
| Research & development | $5.89M | $11.72M | $3.32M | $2.87M | $3.03M | — | -49.7% |
| Selling, general & admin | $43.23M | $43.31M | $35.86M | $33.23M | $40.51M | — | -0.2% |
| Total operating expense | $49.13M | $55.03M | $39.18M | $36.10M | $43.54M | — | -10.7% |
| Operating income | -$22.08M | $15.59M | $14.75M | $11.41M | -$11.23M | — | -241.6% |
| Net interest income | -$5.50M | -$5.19M | -$6.04M | -$6.41M | -$6.55M | — | -6.0% |
| Pre-tax income | -$27.58M | $10.40M | $1.02M | $5.00M | -$17.78M | — | -365.2% |
| Tax provision | $25.00K | $3.77M | $0 | $0 | — | -$514.00K | -99.3% |
| Net income | -$27.60M | $6.63M | $1.02M | $5.00M | -$17.78M | — | -516.6% |
| Net income to common | -$27.60M | $6.63M | $1.02M | $5.00M | -$17.78M | — | -516.6% |
| Basic EPS | -0.74 | 0.18 | 0.03 | 0.14 | -0.50 | — | -511.1% |
| Diluted EPS | -0.74 | 0.17 | 0.03 | 0.13 | -0.50 | — | -535.3% |
| EBIT | -$22.08M | $15.58M | $7.06M | $11.40M | -$11.23M | — | -241.7% |
| EBITDA | -$16.30M | $20.55M | $11.96M | $16.31M | -$6.32M | — | -179.3% |
| Basic shares | 37.23M | 36.81M | 37.15M | 36.79M | 35.83M | — | +1.1% |
| Diluted shares | 37.23M | 38.98M | 38.88M | 38.85M | 35.83M | — | -4.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $94.64M | $72.93M | $74.29M | $52.96M | $66.73M | +29.8% |
| Cash & short-term investments | $94.64M | $72.93M | $74.29M | $52.96M | $66.73M | +29.8% |
| Accounts receivable | $101.26M | $110.89M | $77.60M | $78.82M | $77.06M | -8.7% |
| Inventory | $16.50M | $13.52M | $12.83M | $11.55M | $10.72M | +22.0% |
| Total current assets | $226.38M | $211.75M | $177.60M | $154.89M | $169.53M | +6.9% |
| Property, plant & equipment | $10.72M | $11.04M | $11.35M | $11.67M | $11.90M | -2.9% |
| Goodwill & intangibles | $182.44M | $176.69M | $174.12M | $178.48M | $182.72M | +3.3% |
| Total assets | $419.54M | $399.48M | $363.07M | $345.03M | $364.16M | +5.0% |
| Total current liabilities | $91.44M | $96.30M | $65.40M | $248.88M | $186.99M | -5.0% |
| Current debt | — | — | — | $183.62M | $108.31M | — |
| Long-term debt | $292.09M | $243.18M | $242.87M | $38.48M | $112.50M | +20.1% |
| Total debt | $300.67M | $251.98M | $251.87M | $231.25M | $230.01M | +19.3% |
| Total liabilities | $391.19M | $347.39M | $316.41M | $295.73M | $308.07M | +12.6% |
| Retained earnings | -$184.13M | -$156.52M | -$163.15M | -$164.17M | -$169.16M | -17.6% |
| Shareholder equity | $28.71M | $52.45M | $47.02M | $49.65M | $56.45M | -45.3% |
| Working capital | $134.94M | $115.45M | $112.20M | -$93.99M | -$17.45M | +16.9% |
| Net tangible assets | -$153.73M | -$124.24M | -$127.10M | -$128.82M | -$126.27M | -23.7% |
| Shares issued | 37.27M | 37.23M | 37.03M | 36.71M | 35.65M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$27.60M | $6.63M | $1.02M | $5.00M | -$17.78M | -516.6% |
| Depreciation & amortisation | $5.78M | $4.97M | $4.90M | $4.90M | $4.91M | +16.3% |
| Stock-based compensation | $3.84M | $3.80M | $3.27M | $875.00K | $4.56M | +1.0% |
| Change in working capital | $8.74M | -$11.63M | -$1.69M | -$13.09M | $26.59M | +175.2% |
| Operating cash flow | -$8.99M | $8.41M | $16.59M | -$803.00K | $19.67M | -206.9% |
| Capital expenditure | -$18.20M | -$372.00K | -$225.00K | -$293.00K | -$212.00K | -4,793.3% |
| Investing cash flow | -$18.20M | -$4.73M | -$225.00K | -$293.00K | -$212.00K | -284.8% |
| Financing cash flow | $48.91M | -$5.04M | $4.96M | -$12.67M | $23.00K | +1,069.7% |
| Free cash flow | -$27.20M | $8.04M | $16.36M | -$1.10M | $19.46M | -438.3% |
| End cash position | $94.64M | $72.93M | $74.29M | $52.96M | $66.73M | +29.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
40.20
+1.86% from price
SMA 20
39.69
+3.16% from price
SMA 50
41.25
-0.73% from price
SMA 100
38.72
+5.77% from price
SMA 200
41.21
-0.63% from price
EMA 12
40.43
+1.29% from price
EMA 26
40.42
+1.30% from price
EMA 50
40.19
+1.89% from price
RSI (14)
52.4
Neutral
MACD (12,26,9)
0.00
Hist 0.24
ATR (14)
2.00
4.88% of price
Realised vol 30D
46.8%
Annualised
Bollinger upper
41.78
20, 2σ
Bollinger lower
37.61
20, 2σ
50 / 200 cross
Golden
41.25 vs 41.21
Trend bias
Below 200
-0.63%
Risk profile
Beta vs SPY
1.47
More volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
46.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.0%
Peak to trough
Max drawdown 5Y
-71.2%
Peak to trough
ATR 14
2.00
4.88% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target
Insider Monkey · 3d ago
Harrow's IHEEZO Cuts Patient-Reported Discomfort 58% in Intravitreal-Injection Study
MT Newswires · 3d ago
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
GlobeNewswire · 3d ago
Harrow (HROW) Q2 2026 Earnings Call Transcript
Motley Fool · 5d ago
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
Insider Monkey · 9d ago
Harrow (HROW) Adds New Eye Care Firepower With Product Launch And Acquisition
Simply Wall St. · 11d ago
Harrow Inc (HROW) (Q2 2026) Earnings Call Highlights: Record Demand and Strategic Expansion ...
GuruFocus.com · 11d ago
Harrow Q2 Earnings Call Highlights
MarketBeat · 11d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.